Rebif

Product manufactured by Emd Serono, Inc.

Application Nr Approved Date Route Status External Links
BLA103780 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Rebif Is Indicated For The Treatment Of Relapsing Forms Of Multiple Sclerosis (Ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease, And Active Secondary Progressive Disease, In Adults. Rebif Is An Interferon Beta Indicated For The Treatment Of Relapsing Forms Of Multiple Sclerosis (Ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease, And Active Secondary Progressive Disease, In Adults. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Interferon Beta-1a

Comments